| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Arrail Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.60 |
| 52 Week High | HK$1.64 |
| 52 Week Low | HK$1.60 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | -2.22% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -2.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| I1D | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | -1.8% |
| 1Y | n/a | 24.7% | 13.2% |
Return vs Industry: Insufficient data to determine how I1D performed against the German Healthcare industry.
Return vs Market: Insufficient data to determine how I1D performed against the German Market.
Price Volatility
| I1D volatility | |
|---|---|
| I1D Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: I1D has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine I1D's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,336 | Robert Zou | www.arrailgroup.com |
Arrail Group Limited operates dental hospitals and clinics in China. It operates through Arrail Dental and Rytime Dental brand names. As of September 30, 2021, it operated 111 hospitals and clinics in 15 first- and second-tier cities in China.
Arrail Group Limited Fundamentals Summary
| I1D fundamental statistics | |
|---|---|
| Market cap | €815.43m |
| Earnings (TTM) | -€102.66m |
| Revenue (TTM) | €237.76m |
3.4x
P/S Ratio-7.9x
P/E RatioIs I1D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| I1D income statement (TTM) | |
|---|---|
| Revenue | CN¥1.62b |
| Cost of Revenue | CN¥1.29b |
| Gross Profit | CN¥336.56m |
| Other Expenses | CN¥1.04b |
| Earnings | -CN¥701.03m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.21 |
| Gross Margin | 20.73% |
| Net Profit Margin | -43.18% |
| Debt/Equity Ratio | 8.5% |
How did I1D perform over the long term?
See historical performance and comparison